Centre tightens antibiotic manufacturing rules to combat drug resistance
The Union health ministry has proposed stricter controls on antibiotic and bulk drug manufacturing and distribution to tackle antimicrobial resistance. Fresh manufacturing licences for antimicrobials will now require prior approval from the Central Licensing Authority before state authorities can grant permission, though existing licences remain valid.
Separately, wholesalers dealing in bulk drugs and active pharmaceutical ingredients must obtain a dedicated licence instead of using a common wholesale permit. The changes aim to ensure quality standards through proper bioavailability and stability checks, prevent diversion of controlled substances, and improve tracking of antibiotics. Both draft proposals are open for public comments before finalisation.